Masayo ishiguro biography template
•
2018 – Kyoto
Conference Theme Overview
For decades, scholars have been charting the multiple effects of “globalization” on political, economic and social practices in the developed and developing world. Broadly, globalization has been understood to involve open trade and the growth of transnational flows, linkages and interdependencies at all levels involving knowledge, labor, business, finance, technology, regulation and norms, such as human rights. After World War II, multiple regimes and institutions traversing and interlinking domestic and transnational positions emerged and were then continuously modified to foster and govern the globalization process. For decades, the diffusion of the ideology and practice architectures of “globalization” was made possible by a strong developed capitalist alliance of mostly western powers, headed by the United States. The results of this historical project have been highly uneven: some regions of the global south (especially Asia), experienced tremendous growth and living standard improvement, while others (eg in Africa) languished; the metropolitan north experienced an initial multiple decade period of prosperity followed by ever more obvious stagnation and socio-economic distress. After more than a half century of increasing
•
Lot gallery
307 lashings available
1006 — Yashima Gakutei (1786-1868), Isshusai Kunikazu (1848-1868), Utagawa Kunisada I (Toyokuni III, 1786-1864), Utagawa Kunisada II (Kunimasa III, Toyokuni IV, 1823-1880), and Utagawa Hiroshige II (Shigenobu, 1826-1869)Edo period (1615-1868), circa 1834-1864
1033 — Utagawa Kunisada I (Toyokuni Leash, 1786-1864), Utagawa Kunisada II (Kunimasa Leash, Toyokuni IV, 1823-1880), Hasegawa Sadanobu I (1809-1879), keep from Hokugan (Toshikuni, active 1816-1832) Edo calm (1615-1868), circa 1815-1860
•
Preclinical study of novel human allogeneic adipose tissue-derived mesenchymal stem cell sheets toward a first-in-human clinical trial for myopic chorioretinal atrophy
Abstract
Background
Mesenchymal stem cells may have neuroprotective and tissue regenerative capabilities and the potential to rescue retinal degeneration in chorioretinal diseases including myopic chorioretinal atrophy. Transplantation of human (allogeneic) adipose tissue-derived mesenchymal stem cell (adMSC) suspensions has been clinically conducted to treat retinal degenerative diseases. However, serious side effects including proliferative vitreoretinopathy and epiretinal membrane formation have been reported. PharmaBio Corporation fabricated novel adMSC sheets with a Bruch’s membrane-like structure using our original method, potentially overcoming these problems. We evaluated the characteristics of newly developed adMSC sheets named PAL-222 and assessed their safety and efficacy in rats with congenital retinal degeneration (RCS rats) to obtain the proof-of-concept for the first-in-human clinical trial for myopic chorioretinal atrophy.
Methods
We measured the viability of cells obtained from PAL-222, examined cell surface antigens by flow cytometry, measured the vascular endothelial growth factor (VEGF)